Combination of inhibitors of PRMT1 and PRMT5 has a synergistic cancer cell growth inhibition in pancreatic cancer and DLBCL cell lines and in pancreatic adenocarcinoma xenografts mouse models 48. Here, PRMT1 is linked to pancreatic adenocarcinoma.